Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Wade Clapp

Showing results (61-70 of 117) with videos related to

Pageof 12
Sort By:
Annals of Hematology|March 31, 2004
Epigenetic regulation of tumor suppressors in t(8:21)-containing AMLGenyan Yang, Waleed Khalaf, Louis van de Locht, et al.
Molecular Oncology|May 31, 2021
SIK2 kinase synthetic lethality is driven by spindle assembly defects in FANCA-deficient cellsKa-Kui Chan, Zahi Abdul-Sater, Aditya Sheth, et al.
Human Molecular Genetics|July 13, 2006
Nf1+/- mast cells induce neurofibroma like phenotypes through secreted TGF-beta signalingFeng-Chun Yang, Shi Chen, Travis Clegg, et al.
Molecular and Cellular Biology|July 1, 2005
Transcriptional repression of the Neurofibromatosis-1 tumor suppressor by the t(8;21) fusion proteinGenyan Yang, Waleed Khalaf, Louis van de Locht, et al.
Human Molecular Genetics|May 16, 2019
Cdkn2a (Arf) loss drives NF1-associated atypical neurofibroma and malignant transformationSteven D Rhodes, Yongzheng He, Abbi Smith, et al.
Blood|September 5, 2008
Pak1 regulates multiple c-Kit mediated Ras-MAPK gain-in-function phenotypes in Nf1+/- mast cellsAndrew S McDaniel, Jayme D Allen, Su-Jung Park, et al.
Experimental Hematology|May 29, 2002
Phenotypic correction of primary Fanconi anemia T cells with retroviral vectors as a diagnostic toolHelmut Hanenberg, Sat Dev Batish, Karen E Pollok, et al.
Human Gene Therapy|January 18, 2012
Gene therapy for Fanconi anemia: one step closer to the clinicJakub Tolar, Pamela S Becker, D Wade Clapp, et al.
Oncotarget|February 9, 2018
Chemopreventative celecoxib fails to prevent schwannoma formation or sensorineural hearing loss in genetically engineered murine model of neurofibromatosis type 2Benjamin M Wahle, Eric T Hawley, Yongzheng He, et al.
Pediatric Blood & Cancer|September 17, 2015
Preclinical Evidence for the Use of Sunitinib Malate in the Treatment of Plexiform NeurofibromasMichael J Ferguson, Steven D Rhodes, Li Jiang, et al.
Pageof 12

Showing results (61-70 of 117) with videos related to

Sort By:
Pageof 12
Annals of Hematology|March 31, 2004
Epigenetic regulation of tumor suppressors in t(8:21)-containing AMLGenyan Yang, Waleed Khalaf, Louis van de Locht, et al.
Molecular Oncology|May 31, 2021
SIK2 kinase synthetic lethality is driven by spindle assembly defects in FANCA-deficient cellsKa-Kui Chan, Zahi Abdul-Sater, Aditya Sheth, et al.
Human Molecular Genetics|July 13, 2006
Nf1+/- mast cells induce neurofibroma like phenotypes through secreted TGF-beta signalingFeng-Chun Yang, Shi Chen, Travis Clegg, et al.
Molecular and Cellular Biology|July 1, 2005
Transcriptional repression of the Neurofibromatosis-1 tumor suppressor by the t(8;21) fusion proteinGenyan Yang, Waleed Khalaf, Louis van de Locht, et al.
Human Molecular Genetics|May 16, 2019
Cdkn2a (Arf) loss drives NF1-associated atypical neurofibroma and malignant transformationSteven D Rhodes, Yongzheng He, Abbi Smith, et al.
Blood|September 5, 2008
Pak1 regulates multiple c-Kit mediated Ras-MAPK gain-in-function phenotypes in Nf1+/- mast cellsAndrew S McDaniel, Jayme D Allen, Su-Jung Park, et al.
Experimental Hematology|May 29, 2002
Phenotypic correction of primary Fanconi anemia T cells with retroviral vectors as a diagnostic toolHelmut Hanenberg, Sat Dev Batish, Karen E Pollok, et al.
Human Gene Therapy|January 18, 2012
Gene therapy for Fanconi anemia: one step closer to the clinicJakub Tolar, Pamela S Becker, D Wade Clapp, et al.
Oncotarget|February 9, 2018
Chemopreventative celecoxib fails to prevent schwannoma formation or sensorineural hearing loss in genetically engineered murine model of neurofibromatosis type 2Benjamin M Wahle, Eric T Hawley, Yongzheng He, et al.
Pediatric Blood & Cancer|September 17, 2015
Preclinical Evidence for the Use of Sunitinib Malate in the Treatment of Plexiform NeurofibromasMichael J Ferguson, Steven D Rhodes, Li Jiang, et al.
Pageof 12